Review of molecular mechanisms and implications in Dermatology;Apoptosis. Revisión de mecanismes moleculares e implicaciones en Dermatología

Actas Dermo-Sifiliograficas

Volumn 89, Issue 1-2, 1998, Pages 3-13

  Peñas, Pablo F ^a   Ríos, Luis ^a   Buezo, Guadalupe F ^a   García Díez, Amaro ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Apoptosis; Keratinocyte

Indexed keywords

EID: 17144470953     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Thompson CB. Apoptosis m the pathogenesis and treatment of disease. Science 1995;267:1456-62.
2. Hale AJ, Smith CA, Sutherland LC et al. Apoptosis: molecular regulation of cell death Eur J Biochem 1996;236:1-26.
3. Steller H. Mechanisms and genes of cellular suicide. Science 1995;267:1445-9.
4. Haake AR, Polakowska RR. Cell death by apoptosis in epidermal biology. J Invest Dermatol 1993;101:107-12.
5. Norris DA. Differential control of cell death in the skin. Arch Dermatol 1995;131:945-8.
6. Orrenius S. Apoptosis: molecular mechanisms and implications for human disease. J Int Med 1995;237:529-36.
7. Cohen JJ. Apoptosis. Immunol Today 1993;14:126-30.
8. Meikrantz W, Schlegel R. Apoptosis and the cell cycle. J Cell Bioch 1995;58:160-74.
9. McCall CA, Cohen J. Programmed cell death in terminally dliffeientiating keratinocytes: role of endogenous endonudease. J Invest Dermatol 1991;97:111-4.
10. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1419-56.
11. Duke RC, Ojcius DM, Young JD-E. Cell suicide in health and disease. Sci Am 1996;:48-55.
12. Ramachandra S, Studzinski GP. Morphological and biochemical criteria of apoptosis. En: Studzinski GP ed. Cell growth and apoptosis. A practical aproach. Oxford: IRL. Press 1995:
13. Alnemri ES, Livingston DJ, Nicholson DW et al. Human ICE/CED-3 protease nomendature. Cell 1996;87:171.
14. Fraser A, Evan G. A license to Kill. Cell 1996;85:781-4.
15. Huang B, Eberstadt M, Olejniczak ET, Meadows RP, Pesik SW. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature 1996;384:638-41.
16. Savama K, Yonehara S, Watanabe Y, Miki Y. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J Invest Dermatol 1994;103:330-4.
17. Oishi M, Maeda K, Sugiyama S. Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines. Arch Dermatol Res 1994;286:396-407.
18. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 1995;14:L129-35.
19. Enari M, Talanian RV, Wong WW, Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 1996;380:723-6.
20. Boldin MP, Goncharov, TM Goltsev, W Wallach D. Involvement of MACH a novel MORT1/FAAD-interacting protease; in FAS/APO-1 and TNF receptor-induced cell death. Cell 1996;85:803-15.
21. Cleveland JL, Ihle JL. Contenders in FasL/TNF death signaling. Cell 1995;81:479-82.
22. Barinaga M. Life-death balance within the cell. Science 1996;274:724.
23. Berke G. The CTL's kiss of death. Cell 1995;81:9-12.
24. Harris CC. p53: at the crossroads of molecular carcinogenesis and molecular epidemiology. J Invest Dermatol Symp Proc 1996;1:115-8.
25. Ashkenas J, Werb Z. Proteolysis and the biochemistry of life-or-death decisions. J Exp Med 1996;183:1947-51.
26. Sherr CJ. Mammalian GI cyclins. Cell 1993;73:1059-65
27. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ. Sunlight and sunburn in human skin cancer: p53 apoptosis and tumor promotion. J Invest Dermatol Symp Proc 1996;1:136-42.
28. Burden AD, Stables GI, Campbell I, Thomson W, MacKie RM. Mdm-2 is not induced by p53 in human keratinocytes in vivo. J Cutan Pathol 1996;23:25-9.
29. Casciola-Rosen L, Nicholson DW, Chong T et al. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 1996;183:1957-64.
30. King KL, Cidlowski JA. Cell cycle and apoptosss: common pathways to life and death. J Cell Bioch 1995;58:175-80.
31. Norris DA, Duke R, Whang K, Middleton M. Immunologic cytotoxicity in alopecia areata: apoptosis of dermal papilla cells in alopecia areata. J Invest Dermatol 1995;104:8-9.
32. Henkart PA, Grinstein S. Apoptosis: mitocondria resurrected? J Exp Med 1996;183:1293-5.
33. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993;14:131-6.
34. Cohen N. Exponential growth in apoptosis. Immunol Today 1995;16:346-8.
35. Strasser A. Death of a T cell. Nature 1995;373:385-6.
36. Schwarz A, Bhardwaj R, Aragane Yet al. Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-α in the formation of sunburn cells J Invest Dermatol 1995;104:922-7.
37. Leverkus M, Yaar M, Gilchrest BA. Evidence for W-induced autocrine Fas/Fas ligand-mediated keratinocyte apoptosis. J Invest Dermatol 1996;106:827.
38. Barnadas MA, Colomo L, Curell R, Moragas JMD. Expression of the p53 protein in sun-damaged skin. Acta Derm Venereol (Stockh) 1996;76:203-4.
39. Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME. Wick G. Endothelial cell apoptosis is a primary patho genetic event underlying skin lesions in avian and human scleroderma.J Clin Invest 1996;98:785-92.
40. Khorshid SM, Glover MT, Churchill L, McGiegor JM, Proby CM. p53 immunoreactivity in non-melanoma skin cancer from immunosuppressed and immunocompetent individuals: a comparative study of 246 tumours. J Cutan Pathol 1996;23:229-33.
41. Gilliam AC, Whitaker-Mcnezes D, Korngold R, Mxirphy GF. Apoptosis is the predominant form of epithelial target cell injury in acute experimental graftversus-host disease. J Invest Dermatol 1996;107:377-83.
42. Langley RGB, Walsh N. Nevill T, Tomas L, Rowden G. Apoptosis is the mode of keratinocyte death in cutaneous graftversus-host-disease. J Am Acad Dermatol 1996;35:187-90.
43. Paul C, Wolkesnstein P, Adle H et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 1996;134:710-4.
44. Weedon D, Apoptosis. Adv Dermatol 1990;5:243-56.
45. Cheng J, Zhou T, Liu C et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994;263:1759-62.
46. Hunter T. Braking the cycle. Cell 1993;75:839-41.
47. Mansoor A, McKee PH, Simpson JA, McGuire B, Hobbs C. Prognostic significance of Ki-67 and p53 immunoreactivity in cutaneous squamous cell carcinomas. Am J Dermatopathol 1996;18:351-7.
48. Matsumura T, Yoshihama Y, Kimura T, Shintani S, Alcalde RE. p53 and MDM2 expression in oral squamous cell carcinoma Oncology 1996;53:308-12.
49. Kennedy MM, Blessing K, King G, Kerr KM. Expression of bcl-2 and p53 in Merkel cell carcinoma. Am J Dermatopathol 1996;18:273-7.
50. Bergman R, Ramon M, Kilim S, Lichtig C, Friedman-Birnbaum R. An immunohistochemical study of p53 protein expression in classical Kaposi's sarcoma. Am J Dermatopathol 1996;18:367-70.
51. Morales-Ducret CRJ, van de Rijn M, LeBrun DP, Smoller BR. bcl-2 expression in primary malignacies of the skin. Arch Dermatol 1995;131:909-12.
52. Inohara S, Kitagawa K, Kitano Y. Expression of cyclin D1 and p53 protein in various malignant skin tumors. Dermatology 1996;192:194-8.